Skip to content
10-Q

Quarterly Report

OPTIMER PHARMACEUTICALS INC

0001104659-13-039804

← back to feed
Filed
May 10, 2013 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2013 · May 6, 2013 48.72M sh
Capex Q1 2013 · Mar 31, 2013 $38.83K
Capex Q1 2013 · Mar 31, 2012 $1.23M
Short Term Investments Q1 2013 · Mar 31, 2013 $5.39M
Short Term Investments Q1 2013 · Dec 31, 2012 $4.56M
Cash And Equivalents Q1 2013 · Mar 31, 2013 $87.96M
Cash And Equivalents Q1 2013 · Dec 31, 2012 $119.44M
Cash And Equivalents Q1 2013 · Mar 31, 2012 $22.23M
Cash And Equivalents Q1 2013 · Dec 31, 2011 $31.79M
Stockholders Equity Q1 2013 · Mar 31, 2013 $105.09M
Stockholders Equity Q1 2013 · Dec 31, 2012 $130.81M
Current Liabilities Q1 2013 · Mar 31, 2013 $28.33M
Current Liabilities Q1 2013 · Dec 31, 2012 $26.79M
Current Assets Q1 2013 · Mar 31, 2013 $129.44M
Current Assets Q1 2013 · Dec 31, 2012 $152.02M
Total Assets Q1 2013 · Mar 31, 2013 $135.43M
Total Assets Q1 2013 · Dec 31, 2012 $159.43M
Sga Expense Q1 2013 · Mar 31, 2013 $34M
Sga Expense Q1 2013 · Mar 31, 2012 $25.52M
Rd Expense Q1 2013 · Mar 31, 2013 $9.89M
Rd Expense Q1 2013 · Mar 31, 2012 $11.07M
Operating Income Q1 2013 · Mar 31, 2013 −$31.49M
Operating Income Q1 2013 · Mar 31, 2012 −$34.57M
Cost Of Revenue Q1 2013 · Mar 31, 2013 $1.63M
Cost Of Revenue restated Q1 2013 · Mar 31, 2012 $1.22M
Revenue Q1 2013 · Mar 31, 2013 $19.44M
Revenue Q1 2013 · Mar 31, 2012 $14.38M